Break the barriers: girls' experiences of menstruation in the UK
The UK is one of the richest countries in the world.
The UK is one of the richest countries in the world.
Recognizing the continued vulnerability of young persons within the Caribbean region to the threat posed by the HIV/AIDS epidemic, the Pan Caribbean Partnership Against HIV and AIDS (PANCAP) sought to mobilize resources to aid in mitigating this risk.
Evidence shows that HIV flourishes in conditions of inequality and lack of accountability. In many countries, HIV prevalence continues to rise among women, especially adolescent girls, young women and women from key populations.
El principal propósito de este folleto es ayudar a los católicos que se esfuerzan por encontrar respuestas a preguntas relacionadas con la fe, la conciencia, la sexualidad y el uso de los condones para prevenir el VIH.
This document focuses on the protection of the rights of women and girls In Ethiopia, that may have a relevance to addressing the vulnerability of women and girls to HIV/AIDS.
Não é possível dissociar direitos humanos do enfrentamento das DST/HIV/aids. O processo de reconhecimento do direito ao acesso universal a prevenção, diagnóstico e tratamento constitui importante bandeira de direitos humanos desde o inicio da epidemia.
This booklet is intended for parents who wish to know more about how they can better communicate with their children on sexuality issues.
El programa de educación no formal de la UNESCO para la reducción del impacto por el uso de drogas y el VIH / SIDA busca mitigar la vulnerabilidad de grupos de personas que se encuentran en situación de pobreza.
In 2007, an estimated total of 2 million children were living with HIV - eight times more than in 1990 - while both new infections and deaths among children have grown three-fold globally since 1990.
Advocacy briefing note developed by the UNAIDS Inter-Agency Task Team on Education with the aim of assisting education professionals to advocate for issues related to education sector responses to HIV.